This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Recognised adoption barriers

NICE Adoption scoping report

The NICE Adoption Scoping Report was developed to investigate barriers in prescribing biologics. The report is a high-level summary of some of the common issues raised when speaking about barriers to asthma biologics prescribing for eligible patients. It represents the views of respiratory consultants in both specialist prescribing centres and in secondary care and of GPs.

National benchmarking exercise

Carried out by the AHSN Network, this enabled greater understanding of how different organisations identify patients, what capacity and resources are available, if there are any significant barriers and, most importantly, finding and sharing areas of great clinical practice.

You can read the summary report here.

A review of the patient journey to biologic initiation in UK severe asthma centres

As part of the Accelerated Access Collaborative’s (AAC) asthma biologics rapid uptake programme, Asthma and Lung UK, the AAC and the Severe Asthma Centres in England undertook a data collection exercise to better understand the patient journey to biologic initiation. This is a landmark piece of research which has not been conducted previously and it sets the foundations for the development of an asthma pathway that speeds up appropriate referrals and access to biologic treatments for severe asthma. A summary of the analysis is available here.

Equality and Health Impact Assessment evidence summary

Asthma and Biologics report EHIA and evidence summary

NHS England and NHS Improvement: Equality and Health Inequalities Impact Assessment (EHIA) template


Severe Asthma: Optimal Pathway of Care